Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group
RECOVERY Collaborative Group
Lancet Diabetes Endocrinol. Pub. Online 18 Oct 2023.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
RECOVERY Collaborative Group
Lancet Diabetes Endocrinol. Pub. Online 18 Oct 2023.
Leggi
Rafiei S, Souri S, Nejatifar Z, Amerzadeh M
Diabetes Technol Ther. Pub. online 5 Sep 2023.
Leggi
Sergel-Stringer OT, Al-Sallami HS, Styles SE, et al.
BMC Endocr Disord. 2023;23(1):229.
Leggi
Ramos EL, Dayan CM, Chatenoud L, et al.
NEJM. Pub. online 18 Oct 2023.
Leggi
Russell-Jones D, Babazono T, Cailleteau R, et al.
The Lancet. Pub. online 17 Oct 2023.
Leggi
Ji L, Ahmann AJ, Ahrén B, et al.
Diabetes Obes Metab. Pub. online 12 Oct 2023.
Leggi
Yuan K, Wu B, Zeng R, et al.
Diabetes Obes Metab. Pub. online 9 Oct 2023.
Leggi
Nwokolo M, Lakshman R, Hartnell S, et al.
Diabetes Technol Ther. Pub. online 12 Oct 2023.
Leggi
Butt JH, Docherty KF, Kosiborod MN, et al.
J Am Coll Cardiol HF. 2023, 11 (10) 1411–1423.
Leggi
Lawton J, Kimbell B, Closs M, et al.
Diabetes Technol Ther. Pub. online 5 Oct 2023.
Leggi